Profiel
Thomas Madden currently works at Acuitas Therapeutics, Inc., as President & Chief Executive Officer.
Actieve functies van Thomas Madden
| Bedrijven | Functie | Begin |
|---|---|---|
Acuitas Therapeutics, Inc.
 Acuitas Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Acuitas Therapeutics is a private biotechnology company based in Vancouver, Canada that specializes in developing delivery systems for nucleic acid therapeutics based on lipid nanoparticles. The Canadian company partners with pharmaceutical and biotechnology companies, academic institutes, and non-governmental organizations to advance nucleic acid therapeutics into clinical trials and the marketplace. Acuitas Therapeutics has agreements in place with several partners to use its proprietary lipid nanotechnology in the development of COVID-19 vaccines, including Pfizer/BioNTech for Comirnaty®. The CEO of the company is Thomas Madden. | Algemeen Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Acuitas Therapeutics, Inc.
Acuitas Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Acuitas Therapeutics is a private biotechnology company based in Vancouver, Canada that specializes in developing delivery systems for nucleic acid therapeutics based on lipid nanoparticles. The Canadian company partners with pharmaceutical and biotechnology companies, academic institutes, and non-governmental organizations to advance nucleic acid therapeutics into clinical trials and the marketplace. Acuitas Therapeutics has agreements in place with several partners to use its proprietary lipid nanotechnology in the development of COVID-19 vaccines, including Pfizer/BioNTech for Comirnaty®. The CEO of the company is Thomas Madden. | Commercial Services |
